Shares of Bausch + Lomb (NYSE: BLCO) rallied 15.7% as of 3:07 p.m. ET today.

The stock is surging today on news the company is considering selling itself. Of note, Bausch + Lomb is the eye-care subsidiary of Bausch Health Companies, which was formerly known as Valeant Pharmaceuticals.

Valeant got into trouble nearly a decade ago after using debt to buy up several pharmaceutical companies, then subsequently slashing research budgets and raising prices.

Continue reading

Source Fool.com